Abstract
Many issues regarding the definition, phenomenology, categorization and outcome of nonconvulsive (or dialeptic) status epilepticus are still unresolved. Management is often difficult, with highly variable response to treatment. This classically includes oral benzodiazepines or steroids. New insights into pathophysiological mechanisms involved in sustaining epileptic activity or deficits in seizure termination may lead to improved management programs. Relevant synaptic processes implicate functional alterations of GABA, GABA and NMDA receptor complexes. Early results with NMDA blockers (e.g. ketamine) in animal models and pediatric patients are encouraging. Metabolic approaches have included ketogenic diets. Dynamic approaches of electroencephalographic signals may open the way to neuromodulation through electrical resetting techniques applied at critical phases.
Keywords: Nonconvulsive, phenomenology, NMDA blockers, ketamine
Current Pediatric Reviews
Title: Nonconvulsive (Dialeptic) Status Epilepticus in Children
Volume: 1 Issue: 1
Author(s): Bernard Dan and Stewart G. Boyd
Affiliation:
Keywords: Nonconvulsive, phenomenology, NMDA blockers, ketamine
Abstract: Many issues regarding the definition, phenomenology, categorization and outcome of nonconvulsive (or dialeptic) status epilepticus are still unresolved. Management is often difficult, with highly variable response to treatment. This classically includes oral benzodiazepines or steroids. New insights into pathophysiological mechanisms involved in sustaining epileptic activity or deficits in seizure termination may lead to improved management programs. Relevant synaptic processes implicate functional alterations of GABA, GABA and NMDA receptor complexes. Early results with NMDA blockers (e.g. ketamine) in animal models and pediatric patients are encouraging. Metabolic approaches have included ketogenic diets. Dynamic approaches of electroencephalographic signals may open the way to neuromodulation through electrical resetting techniques applied at critical phases.
Export Options
About this article
Cite this article as:
Dan Bernard and Boyd G. Stewart, Nonconvulsive (Dialeptic) Status Epilepticus in Children, Current Pediatric Reviews 2005; 1 (1) . https://dx.doi.org/10.2174/1573396052953480
DOI https://dx.doi.org/10.2174/1573396052953480 |
Print ISSN 1573-3963 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6336 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Drug Targets from Genetics: Alpha-Synuclein
CNS & Neurological Disorders - Drug Targets Current Perspective of COVID-19 on Neurology: A Mechanistic Insight
Combinatorial Chemistry & High Throughput Screening Multiple Roles of the Extracellular Matrix in Inflammation
Current Pharmaceutical Design Vanutide Cridificar and the QS-21 Adjuvant in Japanese Subjects with Mild to Moderate Alzheimer’ s Disease: Results from Two Phase 2 Studies
Current Alzheimer Research Cellular Delivery In Vivo of siRNA-Based Therapeutics
Current Pharmaceutical Design Dysfunctional Adaptive Immunity During Parasitic Infections
Current Immunology Reviews (Discontinued) The Development of High-throughput Identification and Heterologous Expression of Valuable Peptides/Proteins
Current Proteomics New Molecular Targets of Anticancer Therapy – Current Status and Perspectives
Current Medicinal Chemistry Pharmacogenetics of the Metabolic Disturbances and Atherosclerosis Associated with Antiretroviral Therapy in HIV-Infected Patients
Current Pharmaceutical Design Adverse Effects and Drug Interactions of Biologic Agents
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry The Role of Viruses in Neurodegenerative and Neurobehavioral Diseases
CNS & Neurological Disorders - Drug Targets An Update on the Roles of the Complement System in Autoimmune Diseases and the Therapeutic Possibilities of Anti-Complement Agents
Current Drug Therapy Programmed Symptoms: Disparate Effects United by Purpose
Current Rheumatology Reviews Therapeutical Potential of CB<sub>2</sub> Receptors in Immune-Related Diseases
Current Molecular Pharmacology CCR1 and CCR2 Antagonists
Current Topics in Medicinal Chemistry Gibbs Sampling Shows Possibilities of B-Cell Epitope Signatures
Protein & Peptide Letters The Use of Oncolytic Vaccinia Viruses in the Treatment of Cancer: A New Role for an Old Ally?
Current Gene Therapy Role of Cannabinoids and Endocannabinoids in Cerebral Ischemia
Current Pharmaceutical Design Are Circulating Monocytes as Microglia Orthologues Appropriate Biomarker Targets for Neuronal Diseases? (Supplementry Table)
Central Nervous System Agents in Medicinal Chemistry The FDG-PET Revolution of Medical Imaging – Four Decades and Beyond
Current Molecular Imaging (Discontinued)